Skip to main content

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q4 2024

Institutional positions in UroGen Pharma Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
138
+10 vs. Q3 2024
Shares held
36.3M
+1.15M (+3.3%) vs. Q3 2024
Total value
$386.3M
−$59.5M (−13.3%) vs. Q3 2024
New holders
30
42 more added
Sold out
20
39 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 138 institutions
Q1 2021: 89 institutionsQ2 2021: 82 institutionsQ3 2021: 93 institutionsQ4 2021: 78 institutionsQ1 2022: 84 institutionsQ2 2022: 65 institutionsQ3 2022: 60 institutionsQ4 2022: 64 institutionsQ1 2023: 66 institutionsQ2 2023: 85 institutionsQ3 2023: 101 institutionsQ4 2023: 105 institutionsQ1 2024: 112 institutionsQ2 2024: 115 institutionsQ3 2024: 128 institutionsQ4 2024: 138 institutionsQ1 2025: 140 institutionsQ2 2025: 150 institutionsQ3 2025: 161 institutionsQ4 2025: 167 institutionsQ1 2026: 173 institutionsQ2 2026: 190 institutions
Value heldQ4 2024: $386.3M
Q1 2021: $278.5MQ2 2021: $213.7MQ3 2021: $236.9MQ4 2021: $140.4MQ1 2022: $123.9MQ2 2022: $109.2MQ3 2022: $110.8MQ4 2022: $115.4MQ1 2023: $116.1MQ2 2023: $137.8MQ3 2023: $248.3MQ4 2023: $321.2MQ1 2024: $407.4MQ2 2024: $641.4MQ3 2024: $445.7MQ4 2024: $386.3MQ1 2025: $460.6MQ2 2025: $545.2MQ3 2025: $878.6MQ4 2025: $1.02BQ1 2026: $835.2MQ2 2026: $1.56B
Institutions holding URGN and their total value by quarter
QuarterHoldersValue
Q2 2026190$1.56B
Q1 2026173$835.2M
Q4 2025167$1.02B
Q3 2025161$878.6M
Q2 2025150$545.2M
Q1 2025140$460.6M
Q4 2024138$386.3M
Q3 2024128$445.7M
Q2 2024115$641.4M
Q1 2024112$407.4M
Q4 2023105$321.2M
Q3 2023101$248.3M
Q2 202385$137.8M
Q1 202366$116.1M
Q4 202264$115.4M
Q3 202260$110.8M
Q2 202265$109.2M
Q1 202284$123.9M
Q4 202178$140.4M
Q3 202193$236.9M
Q2 202182$213.7M
Q1 202189$278.5M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q3 2024.

Institutions holding URGN in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Alliancebernstein L.P.199,259$2.12M0.00%+175,859+751.5%Added
Opaleye Management Inc.220,000$2.34M0.41%−184,100−45.6%Reduced
Wells Fargo & Company221,540$2.36M0.00%+5,801+2.7%Added
Citadel Advisors LLC228,785$2.44M0.00%−13,281−5.5%Reduced
Hudson Bay Capital Management LP233,322$2.48M0.02%+233,322New
Rice Hall James & Associates, LLC264,031$2.81M0.15%−7,866−2.9%Reduced
Vanguard Group Inc297,354$3.17M0.00%+12,917+4.5%Added
Cormorant Asset Management, LP300,000$3.19M0.18%−1,250,000−80.6%Reduced
Superstring Capital Management LP301,206$3.21M2.82%+301,206New
Woodline Partners LP305,642$3.26M0.02%00.0%Unchanged
Northern Trust Corp310,074$3.30M0.00%+23,345+8.1%Added
Point72 Asset Management, L.P.317,114$3.38M0.01%−1,189,532−79.0%Reduced
Goldman Sachs Group Inc317,522$3.38M0.00%+1,565+0.5%Added
Stonepine Capital Management, LLC324,324$3.45M2.79%+43,979+15.7%Added
Cantor Fitzgerald, L. P.360,000$3.79M0.14%+360,000New
Parkman Healthcare Partners LLC369,861$3.94M0.52%+22,320+6.4%Added
Price T Rowe Associates Inc393,984$4.20M0.00%+381,145+2,968.7%Added
Geode Capital Management, LLC461,902$4.92M0.00%+6,265+1.4%Added
Harel Insurance Investments & Financial Services Ltd.463,267$4.93M0.08%00.0%Unchanged
DAFNA Capital Management LLC492,515$5.25M1.33%+33,600+7.3%Added
Wildcat Capital Management, LLC495,606$5.28M2.09%00.0%Unchanged
Millennium Management LLC645,785$6.88M0.01%−853,416−56.9%Reduced
Migdal Insurance & Financial Holdings Ltd.686,472$7.31M0.10%00.0%Unchanged
Morgan Stanley767,300$8.17M0.00%−1,414,164−64.8%Reduced
State Street Corp808,053$8.61M0.00%+38,470+5.0%Added
Rosalind Advisors, Inc.870,000$9.27M4.99%+870,000New
UBS Group AG922,698$9.83M0.00%+876,923+1,915.7%Added
Jefferies Financial Group Inc.965,929$10.3M0.11%+929+0.1%Added
Silverarc Capital Management, LLC1,120,473$11.9M2.67%+219,344+24.3%Added
Nantahala Capital Management, LLC1,371,638$14.6M1.02%+1,371,638New
UBS Asset Management Americas Inc1,377,156$14.7M0.00%+36,084+2.7%Added
Acorn Capital Advisors, LLC1,516,303$16.1M8.69%+1,516,303New
Vestal Point Capital, LP1,630,000$17.4M1.03%+1,230,000+307.5%Added
Toronto Dominion Bank1,749,142$18.6M0.04%+1,749,142New
Menora Mivtachim Holdings Ltd.2,303,031$24.5M0.15%00.0%Unchanged
BlackRock, Inc.2,467,211$26.3M0.00%−30,732−1.2%Reduced
Adage Capital Partners GP, L.L.C.2,928,086$31.2M0.05%−807,655−21.6%Reduced
RTW Investments, LP3,834,794$40.8M0.62%+47,447+1.3%Added
Cowen and Company, LLC0$00.00%−1,796,589−100.0%Sold out
StemPoint Capital LP0$00.00%−241,984−100.0%Sold out
AWM Investment Company, Inc.0$00.00%−139,886−100.0%Sold out
Monashee Investment Management LLC0$00.00%−55,000−100.0%Sold out
HighVista Strategies LLC0$00.00%−38,566−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−28,393−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−24,500−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−19,597−100.0%Sold out
Simplex Trading, LLC0$00.00%−19,031−100.0%Sold out
Prudential Financial Inc0$00.00%−17,030−100.0%Sold out
Partners Capital Investment Group, LLP0$00.00%−15,384−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−13,993−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−13,361−100.0%Sold out
NBC Securities, Inc.0$00.00%−647−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−500−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−253−100.0%Sold out
True Wealth Design, LLC0$00.00%−161−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−138−100.0%Sold out
Bessemer Group Inc0$00.00%−85−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−56−100.0%Sold out